FEATURES
RONG Yao, CHENG Jiajia, LIU Yuan, YANG Bo, HUANG Yue, WU Hang
Objective To systematically evaluate the multidimensional impacts of the Beijing volume-based procurement (VBP) policy on the consumption of key high-value medical consumables, cost structure, clinical behaviors, and disciplinary development in neurosurgical interventional procedures, and to provide evidence-based basis for subsequent policy iteration. Methods All neurosurgical interventional cases using flow diverter (FD) in Xuanwu Hospital of Capital Medical University from January 2020 to March 2025 were enrolled. Taking the implementation of VBP on December 15, 2023 as the time node, the cases were divided into the pre-VBP group (1048 cases) and the post-VBP group (942 cases). Patient information, cost and consumable usage data were obtained through the hospital’s multiple data platforms to construct a three-level nested dataset of “case-surgery-consumable”, the various costs, consumable usage and the usage quantity of different types of FD before and after the implementation of VBP were compared, and explored the correlation between FD costs and other indicators. Results All research indicators did not follow a normal distribution. The number of patients undergoing FD implantation surgery increased year by year from 2020 to 2024, while the number of disease diagnosis categories showed no significant change. The average length of hospital stay of patients decreased from 6.34 d to 5.00 d after VBP (Z=6.484, P<0.05). All types of costs decreased significantly after the implementation of VBP (P<0.05), among which the consumable cost had the largest decrease (median decrease: 30860 yuan/case, Z=13.516, P<0.05), and the median total cost decreased by 33110 yuan/case (Z=13.116, P<0.05). The total consumption of consumables per case decreased by 8 units (Z=5.858, P<0.05), while the usage quantity of FD per case had no significant change (P>0.05), and the usage proportion of FD with surface treatment increased significantly (P<0.05). FD consumable cost was strongly positively correlated with consumable cost and total cost (Spearman correlation coefficients: 0.721 and 0.703, respectively, P<0.05), weakly positively correlated with the proportion of consumable cost in total cost, diagnosis and treatment cost, and surgical cost, and weakly correlated with other indicators. Conclusion Through the mechanism of “volume-based pricing+quality guarantee”, the VBP policy realized the intensive use of high-value medical consumables, optimization of cost structure and improvement of clinical efficiency in neurosurgical intervention, providing an empirical scheme for the implementation of “value-based healthcare” in the field of neurosurgery in China.